Cohort Study of Blood Biomarkers for TES

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Chronic Traumatic EncephalopathyTraumatic Encephalopathy, ChronicTraumatic; Encephalopathy, Postcontusional
Interventions
DIAGNOSTIC_TEST

Blood tests, Cognitive function tests, head MRI (plain scan and DTI sequence) examination and head PET (FDG-PET, Tau-PET and Amyloid-PET) examination

"1. Blood tests (30-ml venous blood) for the following items. 1) Transcriptomics and proteomics high-throughput detection and quantitative verification; 2) Exosomal transcriptomics and proteomics high-throughput detection and quantitative verification; 3) Quantitative detection for classical biomarkers of traumatic brain injury, including S100B, GFAP, UCH-L1, NFL, T-Tau and p-Tau181.~2. Cognitive function tests, including RPQ, MMSE and MoCA.~3. Possible head MRI (plain scan and DTI sequence) examination and head PET (FDG-PET, Tau-PET and Amyloid-PET) examination"

Trial Locations (1)

300052

Tianjin Medical University General Hospital, Tianjin

All Listed Sponsors
collaborator

Tianjin Medical University General Hospital

OTHER

lead

Tianjin Medical University

OTHER